{
  "title": "National consultative meeting on COVID-19 vaccine held",
  "link": "https://www.app.com.pk/national/national-consultative-meeting-on-covid-19-vaccine-held/",
  "date_published": "2020-09-14T06:33:00.000Z",
  "source": "APP",
  "content": "ISLAMABAD, Sep 14 (APP):A national level consultative meeting on COVID-19 vaccine in Pakistan was held here on Monday to discuss regulatory framework and practices to comply with global safety standards.\nThe discussion commenced by informing the participants about the political perspectives engulfing COVID-19 vaccine and its international standing at the meeting which was organized by the Health and Population Think Tank (HPTT), Health Services Academy, Ministry of National Health Services, Regulations and Coordination.\nInternational experts on COVID-19 vaccine from Bill and Malinda Gates Foundation, Food and Drug Administration Authority provided technical input on latest COVID-19 developments and regulatory frameworks.\nA detailed discussion took place on how should the communication strategies be shaped and developed, knowing the perception challenges of COVID-19 vaccine in Pakistan and the development of fast-track transparent system for approval and registration of COVID-19 vaccine.\nSpeaking on the occasion, Dr Faisal Sultan, Special Assistant to the Prime Minister on National Health Services affirmed his firm commitment to ensure timely availability of COVID-19 vaccine that complies with global standards of safety and efficacy, once it is approved globally.\nDr Anita Zaidi, Director of Vaccine Development discussed how COVID-19 vaccine development became a geopolitical issue rather than purely technical vaccine development challenge.\nShe briefed about various challenges and potential solutions related to COVID-19 vaccine management.\nDr Sarfraz K Niazi, Advisor on Vaccine Regulations, apprised on regulatory challenges affiliated with COVID-19 vaccine.\nVice Chancellor of HSA and Chair of the National Vaccine Committee apprised the participants about the progress on the issues of COVID-19 vaccine development, registration and implementation.\nOther participants highlighted the issues of equity, effective communication strategies, gender based distribution, costs and subsidies for COVID-19 vaccine.\nThe meeting was concluded by the technical lead of the think tank with a consensus for a timely response and effective decision-making for vaccine selection, regulation, deployment to priority groups and adequate implementation plan for COVID-19 vaccine in Pakistan.\nThe meeting was attended by all the relevant stakeholders, leadership from the Federal and Provincial Health Departments, Ministry of Science and Technology, Ministry of Education, National Command and Control Center (NCOC), Drug Regulatory Authority of Pakistan (DRAP), pharmaceutical sectors and technical experts on infectious diseases from the National Institute of Health (NIH) and Aga Khan University and others.",
  "retrievedAt": "2025-08-11T19:48:11.324Z"
}
